DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Gaudium IVF and Women Health Limited — Monitoring Agency Report

NSE 2 hrs ago·13 Aug 2026, 5:00 pm

Company NSE

A monitoring agency has released a report for the quarter ended June 30, 2026. This report is specifically related to Gaudium IVF and Women Health Limited. The disclosure provides an update on the company's financial or operational status as per the monitoring agency's assessment.

For investors, this update is important as it offers transparency regarding the company's current standing. It allows stakeholders to track the company's progress and any regulatory or compliance observations that might be relevant to their investment decisions.

Investors should watch for the specific details within the report. Any significant findings or changes in the monitoring agency's assessment could impact the company's stock performance and future outlook.